Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-133355

CEO bought 8,000 shares at $3.77 ($30,132)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Spoor Johan M. CEO 2024-12-04 Purchase +8,000 $3.77 $30,132 36,257 D: show line 1 in the form
Open-market purchases · 8,000 sh · avg $3.77 · $30,132
Loading xslF345X05/ownership.xml…